Haitsma, D.

patient implantation device fibrillator shock system subcutaneou heart s-icd therapy fi brillation arrhythmia disease cardiol detection brillation experience transvenou cardioverter-de s-icd system fl uoroscopy complication vector prevention episode fibrillation procedure tachycardia number advantage death bradycardia suture interval idiopathic /min ± sd suture sleeve heart rate follow-up failure infection brugada syndrome trial 70 ± 8 48 ± 5 prophylactic disadvantage ejection fraction pocket cannom ds syndrome xiphoid guideline table block study right indication sleeve brugada rhythm group selection position thrombosis randomized study prophylactic implantations implant cardioverter-de fibrillators myopotential electrode epstein ae vf zone hall wj transvenous device problem characteristic fibrillator system klein h non-sustained vt